Grant of Options

RNS Number : 6083W

Spectral MD Holdings, Ltd.

19 August 2022

 

Spectral MD Holdings, Ltd

("Spectral MD" or the "Company" or the "Group")  

Grant of Options

LONDON, U.K AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has granted options ("Options") over a total of 1,080,000  common stock of US$0.001 ("Common Stock") in the Company ("Shares") to various new employees of the Company in accordance with the Company's 2018 Long Term Incentive Plan . The Options vest over a three-year period from the date of grant, expire after ten years and have an exercise price of 35.5 pence.

For further information, please contact:
Spectral MD Holdings, Ltd.			https://investors.spectralmd.com/
Wensheng Fan, Chief Executive Officer Nils Windler , Chief Financial Officer			via Walbrook PR
SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)			[phone]
Stuart Gledhill / Caroline Rowe (Corporate Finance) Vadim Alexandre / Rob Rees (Sales and Corporate Broking)
Stifel Nicolaus Europe Limited (Joint Broker)			[phone]
Charles Hoare / Ben Maddison / Will Palmer-Brown
Walbrook PR Ltd (Media & Investor Relations)	[phone] or [e-mail]
Sam Allen / Alice Woodings		[phone] / [phone]

About Spectral MD:  

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our  DeepView^®  Wound Imaging System.

www.spectralmd.com

[e-mail]

 

END

 

 

DSHGIGDIBBBDGDC